Chiron Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.35M | Buy |
29,651
+11,412
| +63% | +$903K | 2.04% | 7 |
|
2025
Q1 | $1.64M | Buy |
18,239
+8,005
| +78% | +$719K | 1.49% | 14 |
|
2024
Q4 | $1.02M | Buy |
10,234
+6,623
| +183% | +$659K | 0.96% | 25 |
|
2024
Q3 | $410K | Buy |
3,611
+911
| +34% | +$103K | 0.36% | 70 |
|
2024
Q2 | $334K | Hold |
2,700
| – | – | 0.32% | 78 |
|
2024
Q1 | $356K | Sell |
2,700
-300
| -10% | -$39.6K | 0.32% | 72 |
|
2023
Q4 | $327K | Sell |
3,000
-302
| -9% | -$32.9K | 0.28% | 79 |
|
2023
Q3 | $340K | Buy |
3,302
+1
| +0% | +$103 | 0.29% | 79 |
|
2023
Q2 | $381K | Buy |
3,301
+196
| +6% | +$22.6K | 0.3% | 68 |
|
2023
Q1 | $330K | Sell |
3,105
-900
| -22% | -$95.7K | 0.23% | 82 |
|
2022
Q4 | $444K | Sell |
4,005
-4,600
| -53% | -$510K | 0.31% | 60 |
|
2022
Q3 | $741K | Sell |
8,605
-1,898
| -18% | -$163K | 0.5% | 51 |
|
2022
Q2 | $958K | Sell |
10,503
-6,399
| -38% | -$584K | 0.6% | 39 |
|
2022
Q1 | $1.39M | Buy |
16,902
+1,301
| +8% | +$107K | 0.87% | 23 |
|
2021
Q4 | $1.2M | Sell |
15,601
-7,899
| -34% | -$606K | 0.86% | 23 |
|
2021
Q3 | $1.77M | Buy |
23,500
+2,650
| +13% | +$199K | 1.29% | 12 |
|
2021
Q2 | $1.62M | Sell |
20,850
-1,787
| -8% | -$139K | 1.35% | 13 |
|
2021
Q1 | $1.67M | Buy |
22,637
+13,722
| +154% | +$1.01M | 1.41% | 12 |
|
2020
Q4 | $696K | Buy |
8,915
+2,206
| +33% | +$172K | 0.57% | 29 |
|
2020
Q3 | $531K | Buy |
+6,709
| New | +$531K | 0.43% | 36 |
|